Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Characterizing rare and low-frequency height-associated variants in the Japanese population.

Akiyama M, Ishigaki K, Sakaue S, Momozawa Y, Horikoshi M, Hirata M, Matsuda K, Ikegawa S, Takahashi A, Kanai M, Suzuki S, Matsui D, Naito M, Yamaji T, Iwasaki M, Sawada N, Tanno K, Sasaki M, Hozawa A, Minegishi N, Wakai K, Tsugane S, Shimizu A, Yamamoto M, Okada Y, Murakami Y, Kubo M, Kamatani Y.

Nat Commun. 2019 Sep 27;10(1):4393. doi: 10.1038/s41467-019-12276-5.

2.

Functional variants in ADH1B and ALDH2 are non-additively associated with all-cause mortality in Japanese population.

Sakaue S, Akiyama M, Hirata M, Matsuda K, Murakami Y, Kubo M, Kamatani Y, Okada Y.

Eur J Hum Genet. 2019 Sep 26. doi: 10.1038/s41431-019-0518-y. [Epub ahead of print]

PMID:
31558841
3.

Next-generation sequencing identifies contribution of both class I and II HLA genes on susceptibility of multiple sclerosis in Japanese.

Ogawa K, Okuno T, Hosomichi K, Hosokawa A, Hirata J, Suzuki K, Sakaue S, Kinoshita M, Asano Y, Miyamoto K, Inoue I, Kusunoki S, Okada Y, Mochizuki H.

J Neuroinflammation. 2019 Aug 5;16(1):162. doi: 10.1186/s12974-019-1551-z.

4.

Genome-wide analysis of dental caries and periodontitis combining clinical and self-reported data.

Shungin D, Haworth S, Divaris K, Agler CS, Kamatani Y, Keun Lee M, Grinde K, Hindy G, Alaraudanjoki V, Pesonen P, Teumer A, Holtfreter B, Sakaue S, Hirata J, Yu YH, Ridker PM, Giulianini F, Chasman DI, Magnusson PKE, Sudo T, Okada Y, Völker U, Kocher T, Anttonen V, Laitala ML, Orho-Melander M, Sofer T, Shaffer JR, Vieira A, Marazita ML, Kubo M, Furuichi Y, North KE, Offenbacher S, Ingelsson E, Franks PW, Timpson NJ, Johansson I.

Nat Commun. 2019 Jun 24;10(1):2773. doi: 10.1038/s41467-019-10630-1.

5.

Publisher Correction: Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes.

Malik R, Chauhan G, Traylor M, Sargurupremraj M, Okada Y, Mishra A, Rutten-Jacobs L, Giese AK, van der Laan SW, Gretarsdottir S, Anderson CD, Chong M, Adams HHH, Ago T, Almgren P, Amouyel P, Ay H, Bartz TM, Benavente OR, Bevan S, Boncoraglio GB, Brown RD Jr, Butterworth AS, Carrera C, Carty CL, Chasman DI, Chen WM, Cole JW, Correa A, Cotlarciuc I, Cruchaga C, Danesh J, de Bakker PIW, DeStefano AL, den Hoed M, Duan Q, Engelter ST, Falcone GJ, Gottesman RF, Grewal RP, Gudnason V, Gustafsson S, Haessler J, Harris TB, Hassan A, Havulinna AS, Heckbert SR, Holliday EG, Howard G, Hsu FC, Hyacinth HI, Ikram MA, Ingelsson E, Irvin MR, Jian X, Jiménez-Conde J, Johnson JA, Jukema JW, Kanai M, Keene KL, Kissela BM, Kleindorfer DO, Kooperberg C, Kubo M, Lange LA, Langefeld CD, Langenberg C, Launer LJ, Lee JM, Lemmens R, Leys D, Lewis CM, Lin WY, Lindgren AG, Lorentzen E, Magnusson PK, Maguire J, Manichaikul A, McArdle PF, Meschia JF, Mitchell BD, Mosley TH, Nalls MA, Ninomiya T, O'Donnell MJ, Psaty BM, Pulit SL, Rannikmäe K, Reiner AP, Rexrode KM, Rice K, Rich SS, Ridker PM, Rost NS, Rothwell PM, Rotter JI, Rundek T, Sacco RL, Sakaue S, Sale MM, Salomaa V, Sapkota BR, Schmidt R, Schmidt CO, Schminke U, Sharma P, Slowik A, Sudlow CLM, Tanislav C, Tatlisumak T, Taylor KD, Thijs VNS, Thorleifsson G, Thorsteinsdottir U, Tiedt S, Trompet S, Tzourio C, van Duijn CM, Walters M, Wareham NJ, Wassertheil-Smoller S, Wilson JG, Wiggins KL, Yang Q, Yusuf S; AFGen Consortium; Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium; International Genomics of Blood Pressure (iGEN-BP) Consortium; INVENT Consortium; STARNET, Bis JC, Pastinen T, Ruusalepp A, Schadt EE, Koplev S, Björkegren JLM, Codoni V, Civelek M, Smith NL, Trégouët DA, Christophersen IE, Roselli C, Lubitz SA, Ellinor PT, Tai ES, Kooner JS, Kato N, He J, van der Harst P, Elliott P, Chambers JC, Takeuchi F, Johnson AD; BioBank Japan Cooperative Hospital Group; COMPASS Consortium; EPIC-CVD Consortium; EPIC-InterAct Consortium; International Stroke Genetics Consortium (ISGC); METASTROKE Consortium; Neurology Working Group of the CHARGE Consortium; NINDS Stroke Genetics Network (SiGN); UK Young Lacunar DNA Study; MEGASTROKE Consortium, Sanghera DK, Melander O, Jern C, Strbian D, Fernandez-Cadenas I, Longstreth WT Jr, Rolfs A, Hata J, Woo D, Rosand J, Pare G, Hopewell JC, Saleheen D, Stefansson K, Worrall BB, Kittner SJ, Seshadri S, Fornage M, Markus HS, Howson JMM, Kamatani Y, Debette S, Dichgans M.

Nat Genet. 2019 Jul;51(7):1192-1193. doi: 10.1038/s41588-019-0449-0.

6.

GREP: genome for REPositioning drugs.

Sakaue S, Okada Y.

Bioinformatics. 2019 Oct 1;35(19):3821-3823. doi: 10.1093/bioinformatics/btz166.

7.

Redox-active injectable gel using polyion complex to achieve sustained release of exenatide and enhance therapeutic efficacy for the treatment of type 2 diabetes.

Ishii S, Sakaue S, Nagasaki Y.

J Biomed Mater Res A. 2019 May;107(5):1107-1113. doi: 10.1002/jbm.a.36647. Epub 2019 Mar 19.

PMID:
30720240
8.

Genetic and phenotypic landscape of the major histocompatibilty complex region in the Japanese population.

Hirata J, Hosomichi K, Sakaue S, Kanai M, Nakaoka H, Ishigaki K, Suzuki K, Akiyama M, Kishikawa T, Ogawa K, Masuda T, Yamamoto K, Hirata M, Matsuda K, Momozawa Y, Inoue I, Kubo M, Kamatani Y, Okada Y.

Nat Genet. 2019 Mar;51(3):470-480. doi: 10.1038/s41588-018-0336-0. Epub 2019 Jan 28.

PMID:
30692682
9.

Integration of genetics and miRNA-target gene network identified disease biology implicated in tissue specificity.

Sakaue S, Hirata J, Maeda Y, Kawakami E, Nii T, Kishikawa T, Ishigaki K, Terao C, Suzuki K, Akiyama M, Suita N, Masuda T, Ogawa K, Yamamoto K, Saeki Y, Matsushita M, Yoshimura M, Matsuoka H, Ikari K, Taniguchi A, Yamanaka H, Kawaji H, Lassmann T, Itoh M, Yoshitomi H, Ito H, Ohmura K, R Forrest AR, Hayashizaki Y, Carninci P, Kumanogoh A, Kamatani Y, de Hoon M, Yamamoto K, Okada Y.

Nucleic Acids Res. 2018 Dec 14;46(22):11898-11909. doi: 10.1093/nar/gky1066.

10.

Deep whole-genome sequencing reveals recent selection signatures linked to evolution and disease risk of Japanese.

Okada Y, Momozawa Y, Sakaue S, Kanai M, Ishigaki K, Akiyama M, Kishikawa T, Arai Y, Sasaki T, Kosaki K, Suematsu M, Matsuda K, Yamamoto K, Kubo M, Hirose N, Kamatani Y.

Nat Commun. 2018 Apr 24;9(1):1631. doi: 10.1038/s41467-018-03274-0.

11.

Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes.

Malik R, Chauhan G, Traylor M, Sargurupremraj M, Okada Y, Mishra A, Rutten-Jacobs L, Giese AK, van der Laan SW, Gretarsdottir S, Anderson CD, Chong M, Adams HHH, Ago T, Almgren P, Amouyel P, Ay H, Bartz TM, Benavente OR, Bevan S, Boncoraglio GB, Brown RD Jr, Butterworth AS, Carrera C, Carty CL, Chasman DI, Chen WM, Cole JW, Correa A, Cotlarciuc I, Cruchaga C, Danesh J, de Bakker PIW, DeStefano AL, den Hoed M, Duan Q, Engelter ST, Falcone GJ, Gottesman RF, Grewal RP, Gudnason V, Gustafsson S, Haessler J, Harris TB, Hassan A, Havulinna AS, Heckbert SR, Holliday EG, Howard G, Hsu FC, Hyacinth HI, Ikram MA, Ingelsson E, Irvin MR, Jian X, Jiménez-Conde J, Johnson JA, Jukema JW, Kanai M, Keene KL, Kissela BM, Kleindorfer DO, Kooperberg C, Kubo M, Lange LA, Langefeld CD, Langenberg C, Launer LJ, Lee JM, Lemmens R, Leys D, Lewis CM, Lin WY, Lindgren AG, Lorentzen E, Magnusson PK, Maguire J, Manichaikul A, McArdle PF, Meschia JF, Mitchell BD, Mosley TH, Nalls MA, Ninomiya T, O'Donnell MJ, Psaty BM, Pulit SL, Rannikmäe K, Reiner AP, Rexrode KM, Rice K, Rich SS, Ridker PM, Rost NS, Rothwell PM, Rotter JI, Rundek T, Sacco RL, Sakaue S, Sale MM, Salomaa V, Sapkota BR, Schmidt R, Schmidt CO, Schminke U, Sharma P, Slowik A, Sudlow CLM, Tanislav C, Tatlisumak T, Taylor KD, Thijs VNS, Thorleifsson G, Thorsteinsdottir U, Tiedt S, Trompet S, Tzourio C, van Duijn CM, Walters M, Wareham NJ, Wassertheil-Smoller S, Wilson JG, Wiggins KL, Yang Q, Yusuf S; AFGen Consortium; Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium; International Genomics of Blood Pressure (iGEN-BP) Consortium; INVENT Consortium; STARNET, Bis JC, Pastinen T, Ruusalepp A, Schadt EE, Koplev S, Björkegren JLM, Codoni V, Civelek M, Smith NL, Trégouët DA, Christophersen IE, Roselli C, Lubitz SA, Ellinor PT, Tai ES, Kooner JS, Kato N, He J, van der Harst P, Elliott P, Chambers JC, Takeuchi F, Johnson AD; BioBank Japan Cooperative Hospital Group; COMPASS Consortium; EPIC-CVD Consortium; EPIC-InterAct Consortium; International Stroke Genetics Consortium (ISGC); METASTROKE Consortium; Neurology Working Group of the CHARGE Consortium; NINDS Stroke Genetics Network (SiGN); UK Young Lacunar DNA Study; MEGASTROKE Consortium, Sanghera DK, Melander O, Jern C, Strbian D, Fernandez-Cadenas I, Longstreth WT Jr, Rolfs A, Hata J, Woo D, Rosand J, Pare G, Hopewell JC, Saleheen D, Stefansson K, Worrall BB, Kittner SJ, Seshadri S, Fornage M, Markus HS, Howson JMM, Kamatani Y, Debette S, Dichgans M.

Nat Genet. 2018 Apr;50(4):524-537. doi: 10.1038/s41588-018-0058-3. Epub 2018 Mar 12. Erratum in: Nat Genet. 2019 Jul;51(7):1192-1193.

12.

Patients' demographics of a convenient clinic located in a large railway station in metropolitan Tokyo area.

Tsuda K, Tanimoto T, Sakaue S, Sato T, Kouno K, Hamaki T, Hosoda K, Ohnishi M, Komatsu T, Kami M, Kusumi E.

Medicine (Baltimore). 2018 Jan;97(2):e9646. doi: 10.1097/MD.0000000000009646.

13.

Human genetics contributes to the understanding of disease pathophysiology and drug discovery.

Sakaue S, Okada Y.

J Orthop Sci. 2017 Nov;22(6):977-981. doi: 10.1016/j.jos.2017.07.009. Epub 2017 Aug 19. Review.

14.

Future Directions of Genomics Research in Rheumatic Diseases.

Okada Y, Kishikawa T, Sakaue S, Hirata J.

Rheum Dis Clin North Am. 2017 Aug;43(3):481-487. doi: 10.1016/j.rdc.2017.04.009. Review.

PMID:
28711147
15.

Early-onset parkinsonism in a pedigree with phosphoglycerate kinase deficiency and a heterozygous carrier: do PGK-1 mutations contribute to vulnerability to parkinsonism?

Sakaue S, Kasai T, Mizuta I, Suematsu M, Osone S, Azuma Y, Imamura T, Tokuda T, Kanno H, El-Agnaf OMA, Morimoto M, Nakagawa M, Hosoi H, Mizuno T.

NPJ Parkinsons Dis. 2017 Mar 31;3:13. doi: 10.1038/s41531-017-0014-4. eCollection 2017.

16.

Chronic treatment with a smart antioxidative nanoparticle for inhibition of amyloid plaque propagation in Tg2576 mouse model of Alzheimer's disease.

Boonruamkaew P, Chonpathompikunlert P, Vong LB, Sakaue S, Tomidokoro Y, Ishii K, Tamaoka A, Nagasaki Y.

Sci Rep. 2017 Jun 19;7(1):3785. doi: 10.1038/s41598-017-03411-7.

17.

IMAGES IN CLINICAL MEDICINE. Takayasu's Arteritis.

Sakaue S, Hagino N.

N Engl J Med. 2016 Aug 18;375(7):675. doi: 10.1056/NEJMicm1503040. No abstract available.

18.

Saffold Cardiovirus Infection in a 2-Year-Old Boy with Acute Pancreatitis.

Ito H, Miyagaki S, Sakaue S, Matsui F, Katsumi Y, Otabe O, Torii J, Itagaki T, Himeda T, Okuwa T, Ohara Y.

Jpn J Infect Dis. 2017 Jan 24;70(1):105-107. doi: 10.7883/yoken.JJID.2015.488. Epub 2016 Mar 18.

19.

Ixekizumab for psoriasis.

Tsuda K, Tanimoto T, Takenouchi S, Sakaue S, Komatsu T.

Lancet. 2016 Jan 16;387(10015):225-6. doi: 10.1016/S0140-6736(16)00047-7. Epub 2016 Jan 15. No abstract available.

PMID:
26842296
20.

Associations among the plasma amino acid profile, obesity, and glucose metabolism in Japanese adults with normal glucose tolerance.

Takashina C, Tsujino I, Watanabe T, Sakaue S, Ikeda D, Yamada A, Sato T, Ohira H, Otsuka Y, Oyama-Manabe N, Ito YM, Nishimura M.

Nutr Metab (Lond). 2016 Jan 19;13:5. doi: 10.1186/s12986-015-0059-5. eCollection 2016.

21.

Unilateral proptosis in a woman with asthma.

Sakaue S, Sumitomo S, Fujio K, Yamamoto K.

BMJ Case Rep. 2015 Feb 12;2015. pii: bcr2014207532. doi: 10.1136/bcr-2014-207532. No abstract available.

22.

Tocilizumab-induced leucocytoclastic vasculitis in a patient with rheumatoid arthritis.

Sakaue S, Sumitomo S, Kubo K, Fujio K, Yamamoto K.

Rheumatology (Oxford). 2014 Aug;53(8):1529-30. doi: 10.1093/rheumatology/keu008. Epub 2014 Mar 7. No abstract available.

PMID:
24609062
23.

[A case with recurrent asystole due to breath-holding spells: successful treatment with levetiracetam].

Sakaue S, Chiyonobu T, Moroto M, Morita T, Yoshida M, Morioka S, Tokuda S, Nishimura A, Morimoto M, Hosoi H.

No To Hattatsu. 2012 Nov;44(6):496-8. Japanese. No abstract available.

PMID:
23240534
24.

Overview of Macrophage Migration Inhibitory Factor (MIF) as a Potential Biomarker Relevant to Adiposity.

Nishihira J, Sakaue S.

J Tradit Complement Med. 2012 Jul;2(3):186-91. Review.

25.

Dinuclear single-molecule magnets with porphyrin-phthalocyanine mixed triple-decker ligand systems giving SAP and SP coordination polyhedra.

Sakaue S, Fuyuhiro A, Fukuda T, Ishikawa N.

Chem Commun (Camb). 2012 May 28;48(43):5337-9. doi: 10.1039/c2cc31125a. Epub 2012 Apr 23.

PMID:
22523745
26.

Validation study on the accuracy of echocardiographic measurements of right ventricular systolic function in pulmonary hypertension.

Sato T, Tsujino I, Ohira H, Oyama-Manabe N, Yamada A, Ito YM, Goto C, Watanabe T, Sakaue S, Nishimura M.

J Am Soc Echocardiogr. 2012 Mar;25(3):280-6. doi: 10.1016/j.echo.2011.12.012. Epub 2012 Jan 9.

27.

[A single administration of morphine suppresses the reduction of the systemic immune activity caused by acute inflammatory pain in rats].

Sakaue S, Sunagawa M, Tanigawa H, Saito Y, Guo SY, Okada M, Nakamura A, Arai K, Hisamitsu T.

Masui. 2011 Mar;60(3):336-42. Japanese.

PMID:
21485104
28.

Modulation of eosinophil survival by epinastine hydrochloride, an H1 receptor antagonist, in vitro.

Watase F, Watanabe S, Kanai K, Yamada N, Sakaue S, Asano K, Hisamitsu T, Suzaki H.

In Vivo. 2008 Nov-Dec;22(6):687-91.

29.

Inhibition of angiogenic factor production from murine mast cells by an antiallergic agent (epinastine hydrochloride) in vitro.

Asano K, Furuta A, Kanai K, Sakaue S, Suzaki H, Hisamitsu T.

Mediators Inflamm. 2008;2008:265095. doi: 10.1155/2008/265095.

30.

Knockdown of macrophage migration inhibitory factor disrupts adipogenesis in 3T3-L1 cells.

Ikeda D, Sakaue S, Kamigaki M, Ohira H, Itoh N, Ohtsuka Y, Tsujino I, Nishimura M.

Endocrinology. 2008 Dec;149(12):6037-42. doi: 10.1210/en.2008-0158. Epub 2008 Aug 14.

PMID:
18703634
31.

Effects of replacing metformin with pioglitazone on glycemic control in japanese patients with poorly controlled type 2 diabetes mellitus: A 12-week, open-label, prospective study.

Sakaue S, Kamigaki M, Yoshimura H, Nishimura M.

Curr Ther Res Clin Exp. 2008 Aug;69(4):364-77. doi: 10.1016/j.curtheres.2008.08.005.

32.

Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis.

Ohira H, Tsujino I, Ishimaru S, Oyama N, Takei T, Tsukamoto E, Miura M, Sakaue S, Tamaki N, Nishimura M.

Eur J Nucl Med Mol Imaging. 2008 May;35(5):933-41. Epub 2007 Dec 15.

PMID:
18084757
33.

Pilot study of short-term effects of a novel long-acting oral beraprost in patients with pulmonary arterial hypertension.

Ikeda D, Tsujino I, Sakaue S, Ohira H, Itoh N, Kamigaki M, Ishimaru S, Atsumi T, Nishimura M.

Circ J. 2007 Nov;71(11):1829-31.

34.

Analysis of N-glycan in serum glycoproteins from db/db mice and humans with type 2 diabetes.

Itoh N, Sakaue S, Nakagawa H, Kurogochi M, Ohira H, Deguchi K, Nishimura S, Nishimura M.

Am J Physiol Endocrinol Metab. 2007 Oct;293(4):E1069-77. Epub 2007 Jul 31.

35.

Estimation of beta-cell function from the data of the oral glucose tolerance test.

Sakaue S, Ishimaru S, Ikeda D, Ohtsuka Y, Honda T, Suzuki J, Kawakami Y, Ishii J, Nishimura M.

Am J Physiol Endocrinol Metab. 2007 Jun;292(6):E1575-80. Epub 2007 Feb 6. Erratum in: Am J Physiol Endocrinol Metab. 2009 Feb;296(2):E400.

36.

Recovery of protein-losing enteropathy after living-donor lobar lung transplantation in primary pulmonary hypertension.

Ohira H, Tsujino I, Sakaue S, Ikeda D, Itoh N, Kamigaki M, Ishimaru S, Date H, Sano Y, Shimizu N, Nishimura M.

J Heart Lung Transplant. 2006 Apr;25(4):486-8. Epub 2006 Feb 28.

37.

Combination of 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in assessing cardiac sarcoidosis.

Ishimaru S, Tsujino I, Sakaue S, Oyama N, Takei T, Tsukamoto E, Tamaki N, Nishimura M.

Sarcoidosis Vasc Diffuse Lung Dis. 2005 Oct;22(3):234-5. No abstract available.

PMID:
16315788
38.

Oxidative stress provokes atherogenic changes in adipokine gene expression in 3T3-L1 adipocytes.

Kamigaki M, Sakaue S, Tsujino I, Ohira H, Ikeda D, Itoh N, Ishimaru S, Ohtsuka Y, Nishimura M.

Biochem Biophys Res Commun. 2006 Jan 13;339(2):624-32. Epub 2005 Nov 18.

PMID:
16310164
39.

Promoter polymorphism in the macrophage migration inhibitory factor gene is associated with obesity.

Sakaue S, Ishimaru S, Hizawa N, Ohtsuka Y, Tsujino I, Honda T, Suzuki J, Kawakami Y, Nishihira J, Nishimura M.

Int J Obes (Lond). 2006 Feb;30(2):238-42.

PMID:
16247506
40.

Small cell carcinoma of the lung exclusively localized within the left descending pulmonary artery.

Kamigaki M, Yamazaki K, Tsujino I, Suga M, Sakaue S, Dosaka-Akita H, Nishimura M.

Chest. 2005 Jun;127(6):2273-6.

PMID:
15947349
41.

Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis.

Ishimaru S, Tsujino I, Takei T, Tsukamoto E, Sakaue S, Kamigaki M, Ito N, Ohira H, Ikeda D, Tamaki N, Nishimura M.

Eur Heart J. 2005 Aug;26(15):1538-43. Epub 2005 Apr 4.

PMID:
15809286
42.

Addition of oral sildenafil to beraprost is a safe and effective therapeutic option for patients with pulmonary hypertension.

Ikeda D, Tsujino I, Ohira H, Itoh N, Kamigaki M, Ishimaru S, Sakaue S, Nishimura M.

J Cardiovasc Pharmacol. 2005 Apr;45(4):286-9.

PMID:
15772514
43.

Troglitazone ameliorates abnormal activity of protein tyrosine phosphatase in adipose tissues of Otsuka Long-Evans Tokushima Fatty rats.

Tagami S, Honda T, Yoshimura H, Homma H, Ohno K, Ide H, Sakaue S, Kawakami Y.

Tohoku J Exp Med. 2002 Jul;197(3):169-81.

44.

Elevated serum KL-6 concentrations in patients with diabetes mellitus.

Takahashi T, Takamura K, Sakaue S, Ishii J, Yokouchi H, Nasuhara Y.

J Diabetes Complications. 2002 Sep-Oct;16(5):352-8.

PMID:
12200080
45.

A case of diabetes, deafness, cardiomyopathy, and central sleep apnea: novel mitochondrial DNA polymorphisms.

Sakaue S, Ohmuro J, Mishina T, Miyazaki H, Yamaguchi E, Nishimura M, Fujita M, Nagashima K, Tagami S, Kawakami Y.

Tohoku J Exp Med. 2002 Mar;196(3):203-11.

46.

A case of fulminant type 1 diabetes with elevated rheumatoid factor and the temporal presence of thyroid-stimulating hormone receptor antibody.

Sakaue S, Nagata M, Wakabayashi O, Honda T, Yoshimura H, Yamaguchi E, Nishimura M.

Diabetes Care. 2002 May;25(5):935-6. No abstract available.

PMID:
11978695
47.

Ganglioside GM3 participates in the pathological conditions of insulin resistance.

Tagami S, Inokuchi Ji J, Kabayama K, Yoshimura H, Kitamura F, Uemura S, Ogawa C, Ishii A, Saito M, Ohtsuka Y, Sakaue S, Igarashi Y.

J Biol Chem. 2002 Feb 1;277(5):3085-92. Epub 2001 Nov 13.

48.

Increased glomerular cytosolic phospholipase A2 activity of OLETF rats with early diabetes.

Furuya Y, Tagami S, Hasegawa A, Ishii J, Hirokawa J, Yoshimura H, Honda T, Sakaue S, Aoki K, Murakami M, Kudo I, Kawakami Y.

Exp Clin Endocrinol Diabetes. 1999;107(5):299-305.

PMID:
10482042
49.

Regulation of macrophage migration inhibitory factor (MIF) expression by glucose and insulin in adipocytes in vitro.

Sakaue S, Nishihira J, Hirokawa J, Yoshimura H, Honda T, Aoki K, Tagami S, Kawakami Y.

Mol Med. 1999 Jun;5(6):361-71.

50.

Tumor necrosis factor-alpha regulates the gene expression of macrophage migration inhibitory factor through tyrosine kinase-dependent pathway in 3T3-L1 adipocytes.

Hirokawa J, Sakaue S, Furuya Y, Ishii J, Hasegawa A, Tagami S, Kawakami Y, Sakai M, Nishi S, Nishihira J.

J Biochem. 1998 Apr;123(4):733-9.

Supplemental Content

Loading ...
Support Center